Dayvigo
Chemical Name | lemborexant |
Dosage Form | Tablet (oral; 5 mg, 10 mg) |
Drug Class | Receptor antagonists |
System | Nervous |
Company | Eisai Inc. |
Approval Year | 2019 |
Indication
- Dayvigo is indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.